| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 1 |
| 1 | ARIPIPRAZOLE | 1 |
| 2 | ARIPIPRAZOLE ORAL | 1 |
| 3 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 1 |
| 4 | AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE | 1 |
| 5 | CARBOPLATIN | 1 |
| 6 | CEFADROXIL | 1 |
| 7 | CLOZAPINE | 1 |
| 8 | DIPHENHYDRAMINE | 1 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRASTUZUMAB AND HYALURONIDASE-OYSK | 1 | 0.0093 |
| 1 | AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE | 1 | 0.0008 |
| 2 | CEFADROXIL | 1 | 0.0005 |
| 3 | LITHIUM | 1 | 0.0000 |
| 4 | PERTUZUMAB | 1 | 0.0000 |
| 5 | PROCHLORPERAZINE | 1 | 0.0000 |
| 6 | ERGOCALCIFEROL | 1 | 0.0000 |
| 7 | OSIMERTINIB | 1 | 0.0000 |
| 8 | IRON | 1 | 0.0000 |
| 9 | DOCETAXEL ANHYDROUS | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 2 |
| 1 | Calcium Channel Blocker [EPC] | 1 |
| 2 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 |
| 3 | Endoglycosidase [EPC] | 1 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 1 |
| 5 | Kinase Inhibitor [EPC] | 1 |
| 6 | Microtubule Inhibitor [EPC] | 1 |
| 7 | Osmotic Laxative [EPC] | 1 |
| 8 | Phenothiazine [EPC] | 1 |
| 9 | Platinum-based Drug [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 2 | Phenothiazine [EPC] | 1 | 0.0000 |
| 3 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Atypical Antipsychotic [EPC] | 2 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 8 | Osmotic Laxative [EPC] | 1 | 0.0000 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |